Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Terlipressin Injection

Approval Number

国药准字H20234546

Company杭州沐源生物医药科技有限公司

Registration Date

November 28, 2023

Drug Information

Generic Name

特利加压素注射液

Dosage Form

注射剂

Strength

8.5ml : 0.85mg（按C₅₂H₇₄N₁₆O₁₅S₂计）

Drug Type

化学药品

Registration Date

November 28, 2023

Company Information

Applicant Company

Company Name杭州沐源生物医药科技有限公司

Company Address

浙江省杭州市余杭区五常街道高顺路8-1号C座668室

Manufacturing Company

Company Name山西威奇达光明制药有限公司

Company Address

山西省大同市经济技术开发区第一医药园区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy